IP Library Granted Patent US 7,807,436
Granted Patent B2
US 7,807,436 · App. 11/759,988 · Granted Oct 5, 2010

Recombinant host for producing L-asparaginase II

Assignee: Defiante Farmaceutica, S.A.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,807,436
App. No.
11/759,988
Granted
Oct 5, 2010
Kind
B2
Abstract

The invention provides a recombinant Escherichia coli host cell for producing an Escherichia coli -asparaginase II enzyme. The host cell includes an Escherichia coli chromosome and at least one copy of a recombinant extrachromosomal vector, wherein the recombinant extrachromosomal vector encodes the L-asparaginase II enzyme, wherein the host cell chromosome also encodes the same L-asparaginase II enzyme, and wherein the host chromosome does not encode any other isoform of L-asparaginase II.

Claims (16)

1. A recombinant Escherichia coli host cell for producing an Escherichia coli L-asparaginase II enzyme, comprising an Escherichia coli host cell chromosome and at least one copy of a recombinant extrachromosomal vector, wherein the recombinant extrachromosomal vector encodes a subunit of the L-asparaginase II enzyme, wherein the host cell chromosome also encodes the same subunit of the L-asparaginase II enzyme, and wherein the host cell chromosome does not encode any other isoform of L-asparaginase II, wherein the encoded. L-asparaginase II subunit comprises SEQ ID NO: 1; and

the recombinant extrachromosomal vector comprises a DNA molecule comprising SEQ ID NO: 2.

2. The recombinant Escherichia coli host cell of claim 1 , wherein the extrachromosomal vector is a plasmid.

3. The recombinant Escherichia coli host cell of claim 1 wherein the DNA molecule is operatively connected to a suitable promoter.

4. The recombinant Escherichia coli host cell of claim 3 wherein the promoter is selected from the group consisting of T7, araB, P R /P L , phoA, trc, and trp promoters.

5. The recombinant Escherichia coli host cell of claim 3 wherein the recombinant extrachromosomal vector further comprises an operator, ribosome binding site, signal sequence, transcriptional terminator, antibiotic selection marker, origin of replication, and a regulated copy of the repressor.

6. The recombinant Escherichia coli host cell of claim 3 wherein the host cell chromosome comprises a DNA molecule according to SEQ ID NO:3.

7. An isolated nucleic acid molecule encoding an L-asparaginase II enzyme subunit of SEQ ID NO: 1, wherein the isolated nucleic acid molecule comprises a nucleic acid selected from the group consisting of SEQ ID NO: 2 and SEQ ID NO: 3.

8. A recombinant extrachromosomal vector, wherein the recombinant extrachromosomal vector comprises SEQ ID NO: 2, and encodes a subunit of the L-asparaginase II enzyme.

9. The recombinant extrachromosomal vector of claim 8 wherein the vector is a plasmid.

10. The recombinant extrachromosomal vector of claim 8 wherein the vector is plasmid pEN537.

11. An Escherichia coli host cell comprising the plasmid of claim 10 , that is designated as EN538 and deposited as ATCC Number PTA 7490.

12. A method of producing a recombinant L-asparaginase II enzyme substantially free of other L-asparaginase II isomers, comprising culturing the host cell of claim 11 , and isolating the produced L-asparaginase II enzyme.

13. An isolated DNA molecule encoding a subunit of L-asparaginase II enzyme that comprises SEQ ID NO: 2.

14. The recombinant extrachromosomal vector of claim 8 wherein SEQ ID NO: 2 is operatively connected to a suitable promoter.

15. The recombinant extrachromosomal vector of claim 14 wherein the promoter is selected from the group consisting of T7, araB, P R /P L , phoA, trc, and trp promoters.

Assignments (8)
CHANGE OF ADDRESS Recorded Sep 10, 2019
From: SIGMA-TAU PHARMA LIMITED
To: SIGMA-TAU PHARMA LIMITED
Reel/Frame 050326/0395 →
CHANGE OF NAME Recorded Sep 10, 2019
From: SIGMA-TAU PHARMA LIMITED
To: SERVIER UK IP LIMITED
Reel/Frame 050326/0766 →
CHANGE OF NAME Recorded Sep 10, 2019
From: SERVIER UK IP LIMITED
To: SERVIER IP UK LIMITED
Reel/Frame 050327/0069 →
MERGER Recorded Apr 29, 2015
From: SIGMA TAU RARE DISEASES S.A.
To: SIGMA-TAU PHARMA LIMITED
Reel/Frame 035551/0219 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 7, 2012
From: DEFIANTE FARMACEUTICA, S.A.
To: SIGMA-TAU RARE DISEASES, S.A.
Reel/Frame 027662/0812 →
CORRECTIVE ASSIGNMENT TO CORRECT THE APPLICANT'S ADDRESS MUST BE CORRECTED IN THE ELECTRONIC PATENT ASSIGNMENT SYSTEM PREVIOUSLY RECORDED ON REEL 023937 FRAME 0533. ASSIGNOR(S) HEREBY CONFIRMS THE CORRECT ADDRESS IS RUA DOS FERREIROS 260, FUNCHAL-MADEIRA, PORTUGAL, 9000-082. Recorded Apr 26, 2010
From: ENZON PHARMACEUTICALS, INC.
To: DEFIANTE FARMACEUTICA, S.A.
Reel/Frame 024286/0076 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 16, 2010
From: ENZON PHARMACEUTICALS, INC.
To: DEFIANTE FARMACEUTICA, S.A.
Reel/Frame 023937/0530 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 26, 2007
From: FILPULA, DAVID RAY; WANG, MAOLIANG
To: ENZON PHARMACEUTICALS, INC.
Reel/Frame 019479/0476 →
Continuity (2)
Provisional Application 6081781700 · Jun 30, 2006
Related Publication 20080063632A1 · Mar 13, 2008